Abstracts of the 2nd International Meeting on Antimicrobial Chemotherapy in Clinical Practice, Portofino, Italy, October 21–24, 2001
Identifieur interne : 002420 ( Main/Exploration ); précédent : 002419; suivant : 002421Abstracts of the 2nd International Meeting on Antimicrobial Chemotherapy in Clinical Practice, Portofino, Italy, October 21–24, 2001
Auteurs : D. Bassetti ; M. Bassetti ; G. Tillotson ; S. WatsonSource :
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy [ 0277-0008 ] ; 2001-11.
English descriptors
- Teeft :
- Abnormality, Abscess, Abscess site, Acinetobacter species, Active antiretroviral therapy, Acute exacerbations, Acute infection, Acute infections, Acute malaria, Acute otitis media, Acute pancreatitis, Adverse effects, Adverse events, Aeac, Aeruginosa, Aeruginosa bloodstream infections, Aids patients, Alternative treatment, Amikacin, Aminoglycoside, Amoxicillin, Amphotericin, Ampicillin, Anaerobic, Analogue, Antibacterial, Antibacterial activity, Antibacterial agents, Antibiotic, Antibiotic administration, Antibiotic prophylaxis, Antibiotic resistance, Antibiotic therapy, Antibiotic treatment, Antifungal, Antifungal agents, Antifungal compounds, Antimicrobial, Antimicrobial activity, Antimicrobial agents, Antimicrobial chemotherapy, Antimicrobial resistance, Antimicrobial therapy, Antiretroviral, Antiretroviral agents, Antiretroviral therapy, Antiviral, Assay, Asymptomatic, Atypical, Atypical pathogens, Auic, Aureus, Aureus bacteremia, Aureus strains, Azithromycin, Bacillus, Bacillus subtilis, Bacteremia, Bacteria, Bacterial growth, Bacterial infections, Bacterial meningitis, Bacterial resistance, Bacterial strains, Bactericidal, Bacteriological, Bacteriostatic, Bacteriostatic activity, Baseline, Bassetti, Bassetti department, Blood cultures, Blood samples, Body mass, Brain abscess, Bronchial aspirate, Brucella, Brucellosis, Candida, Candida species, Cardiac, Cardiac involvement, Care unit, Case report, Caseinase, Catarrhalis, Cchd, Ceftazidime, Ceftriaxone, Cefuroxime, Cell count, Cell membrane, Cephalosporin, Cerebrospinal fluid, Chemotherapy, Chlamydia, Chlamydia pneumoniae, Chloramphenicol, Chloroquine, Cholerae, Cholerae strains, Chronic bronchitis, Chronic diarrhea, Chronic hepatitis, Cin1, Cin1 patients, Cin3, Ciprofloxacin, Ciprofloxacin group, Cirrhosis, Clinical, Clinical cases, Clinical course, Clinical microbiology, Clinical outcome, Clinical practice, Clinical signs, Clinical specimens, Clinical studies, Clinical success, Clinical trials, Clone, Clostridium, Cocci, Coli, Combination therapy, Complication, Control group, Cystic fibrosis, Czech republic, Daily regimen, Danbury, Danbury hospital, December, Degli, Degli studi, Derivative, Diabetes mellitus, Diamides, Dicarboxylic acids, Different concentrations, Disease progression, Disk diffusion method, Dos, Dosage regimen, Drug addiction, Dual nucleoside analogues, Effective drug, Elderly people, Elisa, Emergence, Empiric, Empiric therapy, Endocarditis, Enterococci, Enterococcus, Epidemiological, Epidemiological characteristics, Epidemiological data, Epidemiology, Epidermidis, Erythromycin, Esbl, Esbl production, Escherichia, Escherichia coli, Essential oils, Excision, Experimental medicine, Extracellular, Extracellular slime, Febrile, Febrile neutropenia, First case, First time, First visit, Flexneri, Fluoroquinolones, Fungal, Fungal infections, Fungi, Further studies, Gaslini, Gaslini children hospital, Gaslini institute, Gatifloxacin, General hospital, General practitioners, Generation cephalosporins, Genoa, Genotype, Gentamicin, Gentamicine, Giardia lamblia, Glycopeptide, Glycopeptides, Grampositive, Guideline, Haart, Haart introduction, Haemophilus, Haemophilus influenzae, Helicobacter pylori, Hematological, Hematological malignancies, Hepatic, Hepatocellular carcinoma, High fever, High frequency, High level resistance, High levels, High rates, High risk, Histologic, Histologic response, Histological, Histopathological, Hypocholesterolemic patients, Imipenem, Immune, Immune plasma, Immune system, Immunocompromised, Immunocompromised patients, Immunodeficiency, Immunological, Important increase, Inclusion criteria, Infection, Infectious disease, Infectious diseases, Infectious diseases university, Infettive, Inflammation, Influenzae, Inhibitor, Initial therapy, Injection drug, Injection drug users, Injection site, Inpatient, Intensive care unit, Intensive care units, Interferon, Internal medicine, Intervertebral disk, Intravenous, Intravenous amphotericin, Invasive, Ioannina, Iran, Isoniazid, Italy background, January, July, June, Klebsiella, Klebsiella pneumoniae, Lactam, Lactam antibiotics, Lactamase, Lactams, Lagos, Last decade, Lesion, Levofloxacin, Levofloxacin group, Linezolid, Lipid, Lumbar, Lymphocyte, Lymphocyte count, Macrolide, Macrolides, Major cause, Major concern, Malattie, Malignancy, Malnourished children, Martino, Martino hospital, Meat juice, Mechanical ventilation, Median, Median range, Medical microbiology, Medical science, Medical university, Meningitis, Methicillin, Metronidazole, Microbiologic success, Microbiological, Microbiology, Microorganism, Mirabilis, Monotherapy, Moraxella catarrhalis, Morbidity, Moxifloxacin, Mrsa, Multicenter, Multiresistant, Mycobacterium, Mycoplasma pneumoniae, Nalidixic, Nalidixic acid, Neurological signs, Neutropenia, Neutropenic, Neutropenic patients, Newer agents, Nitrofurantoin, Normal mice, Normal prion protein, Nosocomial, Nosocomial infection, Nosocomial pneumonia, Nrti, Nucleoside, October, Ocular lesions, Organisms group, Orsola hospital, Osteomyelitis, Other antibiotics, Other drugs, Other hand, Other virulence factors, Otitis, Outpatient, Paediatric, Pancreatitis, Parenteral, Parenteral therapy, Pathogen, Pathogenesis, Patient, Patient population, Pediatric, Pediatric infections, Pegasys, Peginterferon, Penicillin, Peripheral lipoatrophy, Peritonitis, Pharmacokinetic, Pharmacokinetics, Pharmacotherapy, Pharmacotherapy volume, Phenotype, Plasmid, Pneumococcal, Pneumococcus, Pneumonia, Pneumoniae, Predominant, Present study, Present time, Prion, Prophylaxis, Prosthetic, Protease, Protease inhibitor, Protease inhibitors, Protective effect, Proteus, Proximal tubulopathy, Prsp, Pseudomonas, Pseudomonas aeruginosa, Pylorus, Pyogenes, Quinolone, Quinolones, Radiological, Range months, Recent years, Regimen, Renal, Resistant, Resistant gram, Resistant strains, Respiratory tract infections, Response rates, Retrospective, Rhinocerebral mucormycosis, Ribavirin, Rifampin, Risk factor, Risk factors, Saer database, Safety profiles, Salmonella, Salmonella osteomyelitis, Salvia officinalis, Same period, Sanofi pasteur, Savoia hospital, School children, Second prescriptions, Sepsis, Septic shock, Serious infections, Serious problem, Serum levels, Serum lipid abnormalities, Serum lipid parameters, Several studies, Sexual risk, Shigella, Shigella flexneri, Shigella sonnei, Side effects, Significant difference, Significant increase, Significant reduction, Sinusitis, Slime, Sonnei, Spread peritonitis, Sputum, Staphylococci, Staphylococcus, Staphylococcus aureus, Staphylococcus aureus strains, Streptococci, Streptococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Streptomycin, Studi, Study period, Study year, Such patients, Surgery, Surgical, Surgical patients, Surgical procedure, Surgical wards, Susceptibility, Susceptibility patterns, Susceptibility testing, Syndrome, Teicoplanin, Telithromycin, Terbinafine, Test compounds, Test group, Tetracycline, Therapeutic approaches, Therapeutic options, Therapy, Tolerability, Toxicity, Toxin, Tract infections, Transcriptase inhibitors, Trough concentrations, Tuberculosis, Tumour, Universit, University hospital, Urinary, Urinary tract infection, Urinary tract infections, Urine, Urine samples, Vaccae, Vaccine, Vancomycin, Viral, Viral load, Virologic, Virologic response, Wide range, Worldwide.
Url:
DOI: 10.1592/phco.21.19.331S.34435
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002881
- to stream Istex, to step Curation: 002881
- to stream Istex, to step Checkpoint: 001246
- to stream Main, to step Merge: 002445
- to stream Main, to step Curation: 002420
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Abstracts of the 2nd International Meeting on Antimicrobial Chemotherapy in Clinical Practice, Portofino, Italy, October 21–24, 2001</title>
<author><name sortKey="Bassetti, D" sort="Bassetti, D" uniqKey="Bassetti D" first="D." last="Bassetti">D. Bassetti</name>
</author>
<author><name sortKey="Bassetti, M" sort="Bassetti, M" uniqKey="Bassetti M" first="M." last="Bassetti">M. Bassetti</name>
</author>
<author><name sortKey="Tillotson, G" sort="Tillotson, G" uniqKey="Tillotson G" first="G." last="Tillotson">G. Tillotson</name>
</author>
<author><name sortKey="Watson, S" sort="Watson, S" uniqKey="Watson S" first="S." last="Watson">S. Watson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:184D0AA3F12A127074732545631AE5465DCE37F4</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1592/phco.21.19.331S.34435</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-JVP5BGZ3-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002881</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002881</idno>
<idno type="wicri:Area/Istex/Curation">002881</idno>
<idno type="wicri:Area/Istex/Checkpoint">001246</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001246</idno>
<idno type="wicri:doubleKey">0277-0008:2001:Bassetti D:abstracts:of:the</idno>
<idno type="wicri:Area/Main/Merge">002445</idno>
<idno type="wicri:Area/Main/Curation">002420</idno>
<idno type="wicri:Area/Main/Exploration">002420</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Abstracts of the 2nd International Meeting on Antimicrobial Chemotherapy in Clinical Practice, Portofino, Italy, October 21–24, 2001</title>
<author><name sortKey="Bassetti, D" sort="Bassetti, D" uniqKey="Bassetti D" first="D." last="Bassetti">D. Bassetti</name>
</author>
<author><name sortKey="Bassetti, M" sort="Bassetti, M" uniqKey="Bassetti M" first="M." last="Bassetti">M. Bassetti</name>
</author>
<author><name sortKey="Tillotson, G" sort="Tillotson, G" uniqKey="Tillotson G" first="G." last="Tillotson">G. Tillotson</name>
</author>
<author><name sortKey="Watson, S" sort="Watson, S" uniqKey="Watson S" first="S." last="Watson">S. Watson</name>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy</title>
<title level="j" type="alt">PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY</title>
<idno type="ISSN">0277-0008</idno>
<idno type="eISSN">1875-9114</idno>
<imprint><biblScope unit="vol">21</biblScope>
<biblScope unit="issue">11P3</biblScope>
<biblScope unit="page" from="331S">331S</biblScope>
<biblScope unit="page" to="388S">388S</biblScope>
<biblScope unit="page-count">58</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2001-11">2001-11</date>
</imprint>
<idno type="ISSN">0277-0008</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0277-0008</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term>
<term>Abscess</term>
<term>Abscess site</term>
<term>Acinetobacter species</term>
<term>Active antiretroviral therapy</term>
<term>Acute exacerbations</term>
<term>Acute infection</term>
<term>Acute infections</term>
<term>Acute malaria</term>
<term>Acute otitis media</term>
<term>Acute pancreatitis</term>
<term>Adverse effects</term>
<term>Adverse events</term>
<term>Aeac</term>
<term>Aeruginosa</term>
<term>Aeruginosa bloodstream infections</term>
<term>Aids patients</term>
<term>Alternative treatment</term>
<term>Amikacin</term>
<term>Aminoglycoside</term>
<term>Amoxicillin</term>
<term>Amphotericin</term>
<term>Ampicillin</term>
<term>Anaerobic</term>
<term>Analogue</term>
<term>Antibacterial</term>
<term>Antibacterial activity</term>
<term>Antibacterial agents</term>
<term>Antibiotic</term>
<term>Antibiotic administration</term>
<term>Antibiotic prophylaxis</term>
<term>Antibiotic resistance</term>
<term>Antibiotic therapy</term>
<term>Antibiotic treatment</term>
<term>Antifungal</term>
<term>Antifungal agents</term>
<term>Antifungal compounds</term>
<term>Antimicrobial</term>
<term>Antimicrobial activity</term>
<term>Antimicrobial agents</term>
<term>Antimicrobial chemotherapy</term>
<term>Antimicrobial resistance</term>
<term>Antimicrobial therapy</term>
<term>Antiretroviral</term>
<term>Antiretroviral agents</term>
<term>Antiretroviral therapy</term>
<term>Antiviral</term>
<term>Assay</term>
<term>Asymptomatic</term>
<term>Atypical</term>
<term>Atypical pathogens</term>
<term>Auic</term>
<term>Aureus</term>
<term>Aureus bacteremia</term>
<term>Aureus strains</term>
<term>Azithromycin</term>
<term>Bacillus</term>
<term>Bacillus subtilis</term>
<term>Bacteremia</term>
<term>Bacteria</term>
<term>Bacterial growth</term>
<term>Bacterial infections</term>
<term>Bacterial meningitis</term>
<term>Bacterial resistance</term>
<term>Bacterial strains</term>
<term>Bactericidal</term>
<term>Bacteriological</term>
<term>Bacteriostatic</term>
<term>Bacteriostatic activity</term>
<term>Baseline</term>
<term>Bassetti</term>
<term>Bassetti department</term>
<term>Blood cultures</term>
<term>Blood samples</term>
<term>Body mass</term>
<term>Brain abscess</term>
<term>Bronchial aspirate</term>
<term>Brucella</term>
<term>Brucellosis</term>
<term>Candida</term>
<term>Candida species</term>
<term>Cardiac</term>
<term>Cardiac involvement</term>
<term>Care unit</term>
<term>Case report</term>
<term>Caseinase</term>
<term>Catarrhalis</term>
<term>Cchd</term>
<term>Ceftazidime</term>
<term>Ceftriaxone</term>
<term>Cefuroxime</term>
<term>Cell count</term>
<term>Cell membrane</term>
<term>Cephalosporin</term>
<term>Cerebrospinal fluid</term>
<term>Chemotherapy</term>
<term>Chlamydia</term>
<term>Chlamydia pneumoniae</term>
<term>Chloramphenicol</term>
<term>Chloroquine</term>
<term>Cholerae</term>
<term>Cholerae strains</term>
<term>Chronic bronchitis</term>
<term>Chronic diarrhea</term>
<term>Chronic hepatitis</term>
<term>Cin1</term>
<term>Cin1 patients</term>
<term>Cin3</term>
<term>Ciprofloxacin</term>
<term>Ciprofloxacin group</term>
<term>Cirrhosis</term>
<term>Clinical</term>
<term>Clinical cases</term>
<term>Clinical course</term>
<term>Clinical microbiology</term>
<term>Clinical outcome</term>
<term>Clinical practice</term>
<term>Clinical signs</term>
<term>Clinical specimens</term>
<term>Clinical studies</term>
<term>Clinical success</term>
<term>Clinical trials</term>
<term>Clone</term>
<term>Clostridium</term>
<term>Cocci</term>
<term>Coli</term>
<term>Combination therapy</term>
<term>Complication</term>
<term>Control group</term>
<term>Cystic fibrosis</term>
<term>Czech republic</term>
<term>Daily regimen</term>
<term>Danbury</term>
<term>Danbury hospital</term>
<term>December</term>
<term>Degli</term>
<term>Degli studi</term>
<term>Derivative</term>
<term>Diabetes mellitus</term>
<term>Diamides</term>
<term>Dicarboxylic acids</term>
<term>Different concentrations</term>
<term>Disease progression</term>
<term>Disk diffusion method</term>
<term>Dos</term>
<term>Dosage regimen</term>
<term>Drug addiction</term>
<term>Dual nucleoside analogues</term>
<term>Effective drug</term>
<term>Elderly people</term>
<term>Elisa</term>
<term>Emergence</term>
<term>Empiric</term>
<term>Empiric therapy</term>
<term>Endocarditis</term>
<term>Enterococci</term>
<term>Enterococcus</term>
<term>Epidemiological</term>
<term>Epidemiological characteristics</term>
<term>Epidemiological data</term>
<term>Epidemiology</term>
<term>Epidermidis</term>
<term>Erythromycin</term>
<term>Esbl</term>
<term>Esbl production</term>
<term>Escherichia</term>
<term>Escherichia coli</term>
<term>Essential oils</term>
<term>Excision</term>
<term>Experimental medicine</term>
<term>Extracellular</term>
<term>Extracellular slime</term>
<term>Febrile</term>
<term>Febrile neutropenia</term>
<term>First case</term>
<term>First time</term>
<term>First visit</term>
<term>Flexneri</term>
<term>Fluoroquinolones</term>
<term>Fungal</term>
<term>Fungal infections</term>
<term>Fungi</term>
<term>Further studies</term>
<term>Gaslini</term>
<term>Gaslini children hospital</term>
<term>Gaslini institute</term>
<term>Gatifloxacin</term>
<term>General hospital</term>
<term>General practitioners</term>
<term>Generation cephalosporins</term>
<term>Genoa</term>
<term>Genotype</term>
<term>Gentamicin</term>
<term>Gentamicine</term>
<term>Giardia lamblia</term>
<term>Glycopeptide</term>
<term>Glycopeptides</term>
<term>Grampositive</term>
<term>Guideline</term>
<term>Haart</term>
<term>Haart introduction</term>
<term>Haemophilus</term>
<term>Haemophilus influenzae</term>
<term>Helicobacter pylori</term>
<term>Hematological</term>
<term>Hematological malignancies</term>
<term>Hepatic</term>
<term>Hepatocellular carcinoma</term>
<term>High fever</term>
<term>High frequency</term>
<term>High level resistance</term>
<term>High levels</term>
<term>High rates</term>
<term>High risk</term>
<term>Histologic</term>
<term>Histologic response</term>
<term>Histological</term>
<term>Histopathological</term>
<term>Hypocholesterolemic patients</term>
<term>Imipenem</term>
<term>Immune</term>
<term>Immune plasma</term>
<term>Immune system</term>
<term>Immunocompromised</term>
<term>Immunocompromised patients</term>
<term>Immunodeficiency</term>
<term>Immunological</term>
<term>Important increase</term>
<term>Inclusion criteria</term>
<term>Infection</term>
<term>Infectious disease</term>
<term>Infectious diseases</term>
<term>Infectious diseases university</term>
<term>Infettive</term>
<term>Inflammation</term>
<term>Influenzae</term>
<term>Inhibitor</term>
<term>Initial therapy</term>
<term>Injection drug</term>
<term>Injection drug users</term>
<term>Injection site</term>
<term>Inpatient</term>
<term>Intensive care unit</term>
<term>Intensive care units</term>
<term>Interferon</term>
<term>Internal medicine</term>
<term>Intervertebral disk</term>
<term>Intravenous</term>
<term>Intravenous amphotericin</term>
<term>Invasive</term>
<term>Ioannina</term>
<term>Iran</term>
<term>Isoniazid</term>
<term>Italy background</term>
<term>January</term>
<term>July</term>
<term>June</term>
<term>Klebsiella</term>
<term>Klebsiella pneumoniae</term>
<term>Lactam</term>
<term>Lactam antibiotics</term>
<term>Lactamase</term>
<term>Lactams</term>
<term>Lagos</term>
<term>Last decade</term>
<term>Lesion</term>
<term>Levofloxacin</term>
<term>Levofloxacin group</term>
<term>Linezolid</term>
<term>Lipid</term>
<term>Lumbar</term>
<term>Lymphocyte</term>
<term>Lymphocyte count</term>
<term>Macrolide</term>
<term>Macrolides</term>
<term>Major cause</term>
<term>Major concern</term>
<term>Malattie</term>
<term>Malignancy</term>
<term>Malnourished children</term>
<term>Martino</term>
<term>Martino hospital</term>
<term>Meat juice</term>
<term>Mechanical ventilation</term>
<term>Median</term>
<term>Median range</term>
<term>Medical microbiology</term>
<term>Medical science</term>
<term>Medical university</term>
<term>Meningitis</term>
<term>Methicillin</term>
<term>Metronidazole</term>
<term>Microbiologic success</term>
<term>Microbiological</term>
<term>Microbiology</term>
<term>Microorganism</term>
<term>Mirabilis</term>
<term>Monotherapy</term>
<term>Moraxella catarrhalis</term>
<term>Morbidity</term>
<term>Moxifloxacin</term>
<term>Mrsa</term>
<term>Multicenter</term>
<term>Multiresistant</term>
<term>Mycobacterium</term>
<term>Mycoplasma pneumoniae</term>
<term>Nalidixic</term>
<term>Nalidixic acid</term>
<term>Neurological signs</term>
<term>Neutropenia</term>
<term>Neutropenic</term>
<term>Neutropenic patients</term>
<term>Newer agents</term>
<term>Nitrofurantoin</term>
<term>Normal mice</term>
<term>Normal prion protein</term>
<term>Nosocomial</term>
<term>Nosocomial infection</term>
<term>Nosocomial pneumonia</term>
<term>Nrti</term>
<term>Nucleoside</term>
<term>October</term>
<term>Ocular lesions</term>
<term>Organisms group</term>
<term>Orsola hospital</term>
<term>Osteomyelitis</term>
<term>Other antibiotics</term>
<term>Other drugs</term>
<term>Other hand</term>
<term>Other virulence factors</term>
<term>Otitis</term>
<term>Outpatient</term>
<term>Paediatric</term>
<term>Pancreatitis</term>
<term>Parenteral</term>
<term>Parenteral therapy</term>
<term>Pathogen</term>
<term>Pathogenesis</term>
<term>Patient</term>
<term>Patient population</term>
<term>Pediatric</term>
<term>Pediatric infections</term>
<term>Pegasys</term>
<term>Peginterferon</term>
<term>Penicillin</term>
<term>Peripheral lipoatrophy</term>
<term>Peritonitis</term>
<term>Pharmacokinetic</term>
<term>Pharmacokinetics</term>
<term>Pharmacotherapy</term>
<term>Pharmacotherapy volume</term>
<term>Phenotype</term>
<term>Plasmid</term>
<term>Pneumococcal</term>
<term>Pneumococcus</term>
<term>Pneumonia</term>
<term>Pneumoniae</term>
<term>Predominant</term>
<term>Present study</term>
<term>Present time</term>
<term>Prion</term>
<term>Prophylaxis</term>
<term>Prosthetic</term>
<term>Protease</term>
<term>Protease inhibitor</term>
<term>Protease inhibitors</term>
<term>Protective effect</term>
<term>Proteus</term>
<term>Proximal tubulopathy</term>
<term>Prsp</term>
<term>Pseudomonas</term>
<term>Pseudomonas aeruginosa</term>
<term>Pylorus</term>
<term>Pyogenes</term>
<term>Quinolone</term>
<term>Quinolones</term>
<term>Radiological</term>
<term>Range months</term>
<term>Recent years</term>
<term>Regimen</term>
<term>Renal</term>
<term>Resistant</term>
<term>Resistant gram</term>
<term>Resistant strains</term>
<term>Respiratory tract infections</term>
<term>Response rates</term>
<term>Retrospective</term>
<term>Rhinocerebral mucormycosis</term>
<term>Ribavirin</term>
<term>Rifampin</term>
<term>Risk factor</term>
<term>Risk factors</term>
<term>Saer database</term>
<term>Safety profiles</term>
<term>Salmonella</term>
<term>Salmonella osteomyelitis</term>
<term>Salvia officinalis</term>
<term>Same period</term>
<term>Sanofi pasteur</term>
<term>Savoia hospital</term>
<term>School children</term>
<term>Second prescriptions</term>
<term>Sepsis</term>
<term>Septic shock</term>
<term>Serious infections</term>
<term>Serious problem</term>
<term>Serum levels</term>
<term>Serum lipid abnormalities</term>
<term>Serum lipid parameters</term>
<term>Several studies</term>
<term>Sexual risk</term>
<term>Shigella</term>
<term>Shigella flexneri</term>
<term>Shigella sonnei</term>
<term>Side effects</term>
<term>Significant difference</term>
<term>Significant increase</term>
<term>Significant reduction</term>
<term>Sinusitis</term>
<term>Slime</term>
<term>Sonnei</term>
<term>Spread peritonitis</term>
<term>Sputum</term>
<term>Staphylococci</term>
<term>Staphylococcus</term>
<term>Staphylococcus aureus</term>
<term>Staphylococcus aureus strains</term>
<term>Streptococci</term>
<term>Streptococcus</term>
<term>Streptococcus pneumoniae</term>
<term>Streptococcus pyogenes</term>
<term>Streptomycin</term>
<term>Studi</term>
<term>Study period</term>
<term>Study year</term>
<term>Such patients</term>
<term>Surgery</term>
<term>Surgical</term>
<term>Surgical patients</term>
<term>Surgical procedure</term>
<term>Surgical wards</term>
<term>Susceptibility</term>
<term>Susceptibility patterns</term>
<term>Susceptibility testing</term>
<term>Syndrome</term>
<term>Teicoplanin</term>
<term>Telithromycin</term>
<term>Terbinafine</term>
<term>Test compounds</term>
<term>Test group</term>
<term>Tetracycline</term>
<term>Therapeutic approaches</term>
<term>Therapeutic options</term>
<term>Therapy</term>
<term>Tolerability</term>
<term>Toxicity</term>
<term>Toxin</term>
<term>Tract infections</term>
<term>Transcriptase inhibitors</term>
<term>Trough concentrations</term>
<term>Tuberculosis</term>
<term>Tumour</term>
<term>Universit</term>
<term>University hospital</term>
<term>Urinary</term>
<term>Urinary tract infection</term>
<term>Urinary tract infections</term>
<term>Urine</term>
<term>Urine samples</term>
<term>Vaccae</term>
<term>Vaccine</term>
<term>Vancomycin</term>
<term>Viral</term>
<term>Viral load</term>
<term>Virologic</term>
<term>Virologic response</term>
<term>Wide range</term>
<term>Worldwide</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Bassetti, D" sort="Bassetti, D" uniqKey="Bassetti D" first="D." last="Bassetti">D. Bassetti</name>
<name sortKey="Bassetti, M" sort="Bassetti, M" uniqKey="Bassetti M" first="M." last="Bassetti">M. Bassetti</name>
<name sortKey="Tillotson, G" sort="Tillotson, G" uniqKey="Tillotson G" first="G." last="Tillotson">G. Tillotson</name>
<name sortKey="Watson, S" sort="Watson, S" uniqKey="Watson S" first="S." last="Watson">S. Watson</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002420 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002420 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:184D0AA3F12A127074732545631AE5465DCE37F4 |texte= Abstracts of the 2nd International Meeting on Antimicrobial Chemotherapy in Clinical Practice, Portofino, Italy, October 21–24, 2001 }}
This area was generated with Dilib version V0.6.33. |